BR100 Decreased By (-0.1%)
BR30 Decreased By (-0.35%)
KSE100 Decreased By (-0.44%)
KSE30 Decreased By (-0.72%)
BECO 5.87 Decreased By ▼ -0.16 (-2.65%)
BML 57.90 Increased By ▲ 5.15 (9.76%)
BOP 33.79 Decreased By ▼ -0.46 (-1.34%)
CNERGY 8.16 No Change ▼ 0.00 (0%)
DCL 11.79 Decreased By ▼ -0.55 (-4.46%)
FCCL 53.61 Decreased By ▼ -0.28 (-0.52%)
FCSC 5.42 Increased By ▲ 0.20 (3.83%)
FFL 17.83 Decreased By ▼ -0.20 (-1.11%)
FNEL 1.32 Increased By ▲ 0.02 (1.54%)
HUMNL 11.20 Increased By ▲ 0.20 (1.82%)
KEL 8.00 Decreased By ▼ -0.11 (-1.36%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 88.05 No Change ▼ 0.00 (0%)
NBP 183.95 Decreased By ▼ -2.53 (-1.36%)
PACE 11.64 Increased By ▲ 0.92 (8.58%)
PAEL 40.31 Increased By ▲ 0.37 (0.93%)
PIAHCLA 26.15 Decreased By ▼ -0.02 (-0.08%)
PIBTL 17.24 Decreased By ▼ -0.08 (-0.46%)
PPL 229.70 Decreased By ▼ -3.08 (-1.32%)
PRL 34.51 Decreased By ▼ -0.44 (-1.26%)
PTC 67.65 Increased By ▲ 0.09 (0.13%)
SEARL 90.90 Decreased By ▼ -0.03 (-0.03%)
SSGC 26.86 Decreased By ▼ -0.31 (-1.14%)
TELE 8.56 Decreased By ▼ -0.01 (-0.12%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.35 Increased By ▲ 0.59 (6.74%)
TREET 24.42 Decreased By ▼ -0.12 (-0.49%)
TRG 71.90 Increased By ▲ 0.15 (0.21%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
Pakistan

Anyone 65 and above can register for COVID-19 vaccine from next week: Asad Umar

  • The vaccination of those who register in this category will start in March," Asad Umar tweeted.
  • On February 3, Pakistan began its vaccination drive with the Chinese Sinopharm vaccine.
Published February 10, 2021 Updated February 10, 2021 09:01pm

Minister for Planning and Development Asad Umar announced on Wednesday that registration for coronavirus vaccination for those 65 years and above will be opening next week.

In his tweet, the minister said that vaccination of those who register in this category will start in March. On February 3, Pakistan began its vaccination drive which aims to inoculate over one million healthcare workers with the Chinese Sinopharm vaccine. The Drug Regulatory Authority of Pakistan (DRAP) had approved the Chinese state-owned firm's vaccine for emergency use last month.

DRAP has so far approved Sinopharm's vaccine, Russia's Sputnik V vaccine, and the vaccine developed by Oxford University-AstraZeneca. Meanwhile, COVAX has said that 17 million doses of the Astra­Zeneca vaccine would be provided to Pakistan in the first half of 2021. Around 7million will be available by March.

Since the outbreak of the novel virus last year, Pakistan has confirmed 557,591 cases and 12,128 deaths. Currently, there are 30,512 active COVID-19 cases in the country. Meanwhile, 514,951 people have also recovered from the virus.

Comments

Comments are closed for this article.